TechOps Network Strategy: The presentation mentions different strategies for products in "Introduction/Growth" versus "Mature/Decline" phases. Could you elaborate on how these strategies will be applied to our key products like Xywav or Epidiolex in the coming years?

Questions regarding TechOps Network Strategy The presentation mentions different strategies for products in "Introduction/Growth" versus "Mature/Decline" phases. Could you elaborate on how these strategies will be applied to our key products like Xywav or Epidiolex in the coming years? Regarding the "Make or Buy it?" decision, what are the primary factors that the TOSC considers? How do we balance cost, quality, and supply chain security in these decisions? With the introduction of Epidiolex Capsules, what were the key challenges and learnings from a network strategy perspective, and how will they inform future product launches? Questions regarding Digital, Data & AI / Project Spotlight Project Spotlight is a significant initiative. For the average employee, what will be the most noticeable change when the new Learning Management System (LMS) is implemented? The roadmap for Project Spotlight extends to the end of 2027. What are the key milestones employees should look out for, and how will the project team keep us informed of the progress? Besides the LMS replacement, the presentation mentions 11 other prioritized projects in the Data & AI portfolio. Could you provide some examples of these other projects and the problems they aim to solve?

Given Actio’s KCNT1’s current Phase 2 status, when would Jazz expect to begin Tech Ops onboarding and supply chain design activities?

Is there a name for 926 yet?